Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Rigel Pharmaceuticals Inc. logo

Rigel Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

1.06
 
USD
  
0.04
  
(3.92%)
Optionable: Yes  Market Cap: 178 M  90-day average vol: 1,169,436

Previous close: 1.02  Open: 1.04  Bid: 1.04  Ask: 1.08
52 week range    
0.67   
   2.04
Peers   
CCXI / 
AZN / 
SGMO / 
INFI / 
THRX / 
AMGN / 
ACUR / 
Last updated: Thursday 30th November 2023
41
MarketXLS Rank
40
Value
46
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ACUR

0 B-11.40.47696

AMGN

0.0347129 B23.4223.53

AZN

CCXI

2 B-15.427.82

INFI

0 B-2.21.24

SGMO

1 B-4.75.72

THRX

0 B-7.911.06

XOMA

0 B138.120.07
Financials

RIGL Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization-100000.0
Amortization of intangibles-100000.0
Basic EPS total-0.18-0.11-0.34
Basic weighted shares outstanding87 M88 M88 M94 M126 M161 M167 M169 M170 M172 M
Cost of sales9 M-287000.0-906000.0-895000.0-1 M-2 M
Depreciation-3 M-2 M-1 M-941000.0-465000.0-594000.0-683000.0-706000.0-1 M
DepreciationAndAmortization-3 M-2 M-1 M-941000.0-465000.0-594000.0-683000.0-706000.0-1 M
Diluted EPS total-1.02-1.04-0.58-0.73-0.62-0.44-0.4-0.18-0.11-0.34
Diluted weighted shares outstanding87 M87 M89 M95 M144 M168 M169 M169 M170 M172 M
GainOnSaleOfPPE16000.098000.057000.088000.0732000.0
GainOnSaleOfSecurity64000.032000.056000.023000.083000.027000.0
GeneralAndAdministrativeExpense20 M23 M18 M21 M-7 M-6 M-6 M-6 M-6 M-6 M
Gross operating profit7 M-1 M29 M20 M4 M44 M58 M108 M148 M118 M
Income before tax-89 M-91 M-51 M-69 M-78 M-70 M-67 M-30 M-17 M-59 M
Income restructuring and M&A2 M-1 M-1 M6 M-319000.04 M1 M
Income taxes605000.0
Interest income426000.0243000.0222000.0437000.0892000.02 M3 M582000.047000.0684000.0
InterestExpenseNonOperating335000.01 M5 M4 M
Net income from total operations-89 M-91 M-51 M-69 M-78 M-70 M-67 M-30 M-18 M-59 M
NetIncomeCommonStockholders-89 M-91 M-51 M-69 M-78 M-70 M-67 M-30 M-18 M-59 M
NetIncomeContinuousOperations-89 M-91 M-51 M-69 M-78 M-70 M-67 M-30 M-18 M-59 M
NetIncomeDiscontinuousOperations445000.02 M7 M618000.07 M18000.0496000.086000.0
NetNonOperatingInterestIncomeExpense426000.0243000.0222000.0437000.0892000.02 M2 M-771000.0-5 M-3 M
Operating income-88 M-91 M-52 M-64 M-80 M-73 M-69 M-29 M-9 M-54 M
Operating income before depreciation (EBITDA)-86 M-89 M-50 M-68 M-78 M-70 M-66 M-28 M-11 M-54 M
OperatingExpense95 M90 M81 M84 M84 M117 M127 M137 M157 M173 M
Other income net-16000.0-98000.0-57000.0-88000.0-732000.0-27000.0-700000.0
OtherGandA20 M23 M18 M21 M-7 M-6 M-6 M-6 M-6 M-6 M
OtherImpairmentOfCapitalAssets-700000.0
OtherOperatingExpenses-452000.0-373000.0-572000.0-957000.0-527000.0-419000.0-5 M-5 M-5 M-5 M
PromotionAndAdvertising-3 M
ProvisionForGainLossOnDisposal445000.02 M7 M618000.07 M18000.0496000.086000.0
RentAndLandingFees20 M23 M18 M21 M-7 M-6 M
Research & development expense75 M68 M63 M63 M46 M47 M53 M60 M65 M60 M
ResearchExpense75 M68 M63 M63 M46 M47 M53 M60 M65 M60 M
RestructringAndMnAIncome2 M-1 M-1 M6 M-319000.04 M1 M
SalariesAndWages-7 M-10 M-7 M-8 M-6 M-8 M-9 M-7 M-9 M-12 M
Selling Gen & administrative expense20 M23 M18 M21 M38 M70 M75 M77 M92 M112 M
SellingAndMarketingExpense38 M70 M75 M77 M92 M112 M
SellingExpense38 M70 M75 M77 M92 M112 M
Special income/charges-2 M1 M1 M-6 M319000.0-4 M-1 M
Total Income available for interest expense (EBIT)-89 M-91 M-51 M-69 M-78 M-70 M-67 M-28 M-12 M-55 M
Total common shares outstanding88 M88 M91 M122 M147 M167 M169 M170 M172 M174 M
Total net income-89 M-91 M-51 M-69 M-78 M-70 M-67 M-30 M-18 M-59 M
Total ordinary shares174 M174 M174 M174 M174 M174 M174 M174 M174 M174 M
Total revenues7 M8 M29 M20 M4 M45 M59 M109 M149 M120 M
TotalExpenses95 M99 M81 M84 M84 M117 M127 M136 M156 M171 M
TotalRevenue7 M8 M29 M20 M4 M45 M59 M109 M149 M120 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today